Scientists from the Krembil Brain Institute and the University of Toronto have made an exciting discovery that could open new ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Researchers evidence suggests it’s the lessening of amyloid-beta in the brain that is behind cognitive decline.

Paraquat exposure and its link to Parkinson’s disease is leading to policy battles within California and nationwide.

Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their findings suggest that restoring copper balance could offer new treatments for disorders ...

Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...

Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.

Gloria Elise Durling, 77, of Las Vegas passed away on September 13, 2024, after battling Parkinson's disease for 13 years.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...